February 24, 2025
The American Society of Clinical Oncology (ASCO) has released updated guidelines for neoadjuvant chemotherapy in newly diagnosed advanced ovarian cancer, introducing changes in patient selection and […]
February 24, 2025
TOPLINE: Among Medicare beneficiaries with advanced cancer, 45% had more than one acute care visit, in-hospital mortality, late receipt of systemic therapy, or hospice entry in […]
February 21, 2025
The use of oral contraceptives and a greater number of live births both reduced the risk of ovarian cancer, according to a new analysis of a […]
February 21, 2025
TOPLINE: Mammography supported by artificial intelligence (AI) increased breast cancer detection by 29% compared with standard double reading and reduced screen-reading workload by 44.2%, a trial […]
February 21, 2025
Adjuvant therapy with nivolumab (Opdivo, “nivo”) continues to show disease-free survival (DFS) and overall survival (OS) benefits compared with placebo among patients with muscle-invasive bladder cancer […]
February 20, 2025
The National Institute for Health and Care Excellence (NICE) has approved a chimeric antigen receptor (CAR) T-cell therapy for adults with large B-cell lymphoma. The treatment significantly […]
February 20, 2025
A diet high in omega-3 and low in omega-6 fatty acids, alongside fish oil supplements, may curb the growth of prostate cancer cells in men with […]
February 20, 2025
Transdermal estradiol patches — the same ones used to curb menopause symptoms in women — are an effective alternative to luteinizing hormone–releasing hormone agonists to lower […]
February 20, 2025
As burnout rates soar among oncologists and other healthcare professionals, 2025 kicked off with a dedicated 2-day meeting addressing this urgent issue. Organized by the European […]